IFG
ONCY

Independent Financial Group’s Oncolytics Biotech ONCY Stock Holding History

Independent Financial Group’s Portfolio ONCY Stock Details ONCY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-11,081
Closed -$6.08K – 1344
2025
Q1 		$6.08K Buy
+11,081
New +$8.11K ﹤0.01% 1173

Other funds holding ONCY

SI
Seeds Investor New York $735M AUM 17.54% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
CIBC World Market
CIBC World Market Toronto, Ontario, Canada $61.3B AUM 39.33% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
HL
HeadInvest LLC Portland, Maine $488M AUM 14.33% 1-Year Est. Return
BPWM
Badgley Phelps Wealth Managers Seattle, Washington $5.71B AUM 30.33% 1-Year Est. Return

Independent Financial Group's ONCY Position: Q2 2025 in Review

Independent Financial Group sold out of Oncolytics Biotech (ONCY) in Q2 2025, closing a stake of 11,081 shares — an estimated $6.08K sold.

Independent Financial Group first reported a position in ONCY in Q1 2025 and held it in 1 quarter. The position peaked at $6.08K in Q1 2025. 55 funds tracked by Wall St. Rank hold ONCY as of Q2 2025.

  • Independent Financial Group reported no remaining Oncolytics Biotech position as of Q2 2025 after selling out during the quarter.
  • Independent Financial Group sold 11,081 Oncolytics Biotech shares in Q2 2025, an estimated $6.08K.
  • Independent Financial Group first reported a position in Oncolytics Biotech in Q1 2025 and held it in 1 quarter.
  • Independent Financial Group's Oncolytics Biotech position peaked at $6.08K in Q1 2025.
  • 55 funds tracked by Wall St. Rank held Oncolytics Biotech as of Q2 2025.

Based on Independent Financial Group's 13F filing for Q2 2025, filed 15 May 2026.